Losartan Potassium and Hydrochlorothiazide
- Product NDC
- 57297-216
- 11-digit product format
- 572970216
- Labeler code
- 57297
- Product ID
- 57297-216_40e5d119-b44e-4d48-afe6-8406fb57c488
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Losartan Potassium and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- LUPIN LIMITED
- Application
- ANDA078245
- Marketing category
- ANDA
- Marketing start
- 2010-10-06
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57297-216-01 | 2024-12-19 | C162847 | 48780-1 | 9d75b9d0-8b8a-f424-e053-dadaa90a57ce | 8a0f252d-0a5b-4fa1-91db-21525b2ed2b0 |
| 57297-216-03 | 2024-12-19 | C162847 | 48780-1 | 9d75b9d0-8b8a-f424-e053-dadaa90a57ce | 8a0f252d-0a5b-4fa1-91db-21525b2ed2b0 |
| 57297-216-06 | 2024-12-19 | C162847 | 48780-1 | 9d75b9d0-8b8a-f424-e053-dadaa90a57ce | 8a0f252d-0a5b-4fa1-91db-21525b2ed2b0 |
| 57297-216-09 | 2024-12-19 | C162847 | 48780-1 | 9d75b9d0-8b8a-f424-e053-dadaa90a57ce | 8a0f252d-0a5b-4fa1-91db-21525b2ed2b0 |
| 57297-216-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8b8a-f424-e053-dadaa90a57ce | 8a0f252d-0a5b-4fa1-91db-21525b2ed2b0 |
| 57297-216-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8b8a-f424-e053-dadaa90a57ce | 8a0f252d-0a5b-4fa1-91db-21525b2ed2b0 |
| 57297-216-06 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8b8a-f424-e053-dadaa90a57ce | 8a0f252d-0a5b-4fa1-91db-21525b2ed2b0 |
| 57297-216-09 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8b8a-f424-e053-dadaa90a57ce | 8a0f252d-0a5b-4fa1-91db-21525b2ed2b0 |